Annals of Emergency Medicine
Volume 55, Issue 5 , Pages 412-414 , May 2010

Lack of Antibiotic Efficacy for Simple Abscesses: Have Matters Come to a Head?

  • David A. Talan, MD

      Affiliations

    • Corresponding Author InformationAddress for correspondence: David A. Talan, MD, Department of Emergency Medicine, Olive View–UCLA Medical Center, 14445 Olive View Drive, North Annex, Sylmar, CA 91342; 818-364-3107, fax 818-364-3268

References 

  1. Hammond SP. Management of skin and soft-tissue infection—polling results. N Engl J Med. 2008;359:e20
  2. Duong M, Markwell S, Peter J, et al. Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient. Ann Emerg Med. 2010;55:401–407
  3. Pallin D, Egan J, Pelletier A, et al. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med. 2008;51:291–298
  4. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant Staphylococcus aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666–674
  5. Ellis MW, Hospenthal DR, Dooley DP, et al. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis. 2004;39:971–979
  6. Talan DA. MRSA: deadly super bug or just another staph?. Ann Emerg Med. 2008;51:299–302
  7. Macfie J, Harvey J. The treatment of acute superficial abscesses: a prospective clinical trial. Br J Surg. 1977;64:264–266
  8. Meislin HW, Lerner SA, Graves MH, et al. Cutaneous abscesses (Anaerobic and aerobic bacteriology and outpatient management). Ann Intern Med. 1977;87:145–149
  9. Llera JL, Levy RC, Staneck JL. Cutaneous abscesses: natural history and management in an outpatient facility. J Emerg Med. 1984;1:489–493
  10. Llera JL, Levy RC. Treatment of cutaneous abscess: a double-blind clinical study. Ann Emerg Med. 1985;14:15–19
  11. Lee MC, Rios AM, Aten MF, et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis. 2004;23:123–127
  12. Ruhe J, Smith N, Bradsher R, et al. Community-onset methicillin-resistant Staphylococcus aureus skin and soft tissue infections: impact of antimicrobial therapy. Clin Infect Dis. 2007;44:777–784
  13. Szumowski JD, Cohen DE, Kanaya F, et al. Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic. Antimicrob Agents Chemother. 2007;51:423–428
  14. Rajendran P, Young D, Maurer T, et al. Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk of community-acquired methicillin-resistant Staphylococcus aureus infection. Antimicrob Agents Chemother. 2007;55:4044–4048
  15. Fitch MT, Manthey DE, McGinnis HD, et al. Abscess incision and drainage. N Engl J Med. 2007;357:e20
  16. O'Malley GF, Dominici P, Giraldo P, et al. Routine packing of simple cutaneous abscesses is painful and probably unnecessary. Acad Emerg Med. 2009;16:470–473
  17. Shastry L, Rahimian J, Lascher S. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections in men who have sex with men in New York City. Arch Intern Med. 2007;167:854–857
  18. Frazee BW, Lynn J, Charlebois ED, et al. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft-tissue infections. Ann Emerg Med. 2005;45:311–320
  19. Gorwitz RJ, Kruszon-Moran D, McAllister SK, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis. 2008;197:1226–1234
  20. Ellis MW, Griffith ME, Dooley DP, et al. Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial. Antimicrob Agents Chemother. 2007;51:3591–3598

 Supervising editor: Steven M. Green, MD

 Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article that might create any potential conflict of interest. The author has stated that no such relationships exist. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement.

 Reprints not available from the author.

PII: S0196-0644(10)00214-3

doi: 10.1016/j.annemergmed.2010.02.024

Annals of Emergency Medicine
Volume 55, Issue 5 , Pages 412-414 , May 2010